Repeat hepatectomy for colorectal liver metastasis with rates of second and third hepatectomy: time-to-recurrence and overall survival in a population-derived cohort
HPB · 2026
DOI: 10.1016/j.hpb.2025.11.006 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift HPB, 2026. Verfasst von Torhild Veen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway; Gastrointestinal Translational Research Group, Laboratory f…. Hauptthemen laut MEDLINE: Hepatectomy, Liver Neoplasms, Colorectal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stavanger Universitetssjukehus, Helse Vest RHF.
Abstract (Originalsprache)
BACKGROUND: Repeat hepatectomy for recurrent colorectal liver metastasis (CRLM) is offered to selected patients but with limited data from population-derived cohorts related to outcomes. METHOD: An observational cohort study of patients who underwent an index hepatectomy for CRLM within a population-defined region. Clinicopathological and molecular data were recorded. Overall and recurrence-free survival was calculated. RESULTS: 192 patients (245 hepatectomies) were included, of which 91 (47%) patients developed liver-recurrence after index hepatectomy, and 43 patients (47%) were offered a second repeat hepatectomy; 28 (64%) patients developed a further new liver-recurrence and 8 (29%) had a third re-hepatectomy. There was no clinicopathological difference between patients offered repeat hepatectomy and those that were not. Extrahepatic metastasis occurred more often in those with no repeat surgery (n = 30, 63%) than in the repeat hepatectomy group (n = 7, 16%; P < 0.001). Overall survival after first hepatectomy was 46 months (IQR 15-73). For patients offered hepatectomy, estimated median overall survival was 60 months (IQR 36-159). Median recurrence-free survival after repeat surgery was 6 months (IQR 3-22). CONCLUSION: Repeat surgery for CRLM in a non-selected cohort offers favorable long-term overall survival, although recurrence free survival is short. Extrahepatic recurrence was the most prevalent factors negating further hepatectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway; Gastrointestinal Translational Research Group, Laboratory for Molecular Medicine, Stavanger University Hospital, Stavanger, Norwa…
- Gastrointestinal Translational Research Group, Laboratory for Molecular Medicine, Stavanger University Hospital, Stavanger, Norway; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.
Förderung
- Stavanger Universitetssjukehus
- Helse Vest RHF
Zitieren
APA
Veen, T., Lea, D., Roalsø, M., & Søreide, K. (2026). Repeat hepatectomy for colorectal liver metastasis with rates of second and third hepatectomy: time-to-recurrence and overall survival in a population-derived cohort. HPB. https://doi.org/10.1016/j.hpb.2025.11.006
Vancouver
Veen T, Lea D, Roalsø M, Søreide K. Repeat hepatectomy for colorectal liver metastasis with rates of second and third hepatectomy: time-to-recurrence and overall survival in a population-derived cohort. HPB. 2026. doi:10.1016/j.hpb.2025.11.006
BibTeX
@article{Veen2026,
author = {Veen, Torhild and Lea, Dordi and Roalsø, Marcus and Søreide, Kjetil},
title = {Repeat hepatectomy for colorectal liver metastasis with rates of second and third hepatectomy: time-to-recurrence and overall survival in a population-derived cohort},
journal = {HPB},
year = {2026},
doi = {10.1016/j.hpb.2025.11.006}
}
EUVIMED